Diclofenac Suppository to Control Pain During Flexible Cystoscopy
Launched by AGA KHAN UNIVERSITY · Mar 15, 2013
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • All male patients aged 18 and above
- • Visiting for evaluation of Haematuria or
- • Lower urinary tract symptoms (which include poor steam of urine,intermittency, hesitancy, incomplete voiding of urine, increase urgency, increase frequency, nocturia and urge incontinence)
- • For removal of double J ureteral stent will be included in the study.
- Exclusion criteria:
- • Patients with clinical evidence of urethral stricture and/or prostatitis,
- • Patients in which biopsy will be taken,
- • those having psychiatric illness,
- • Asthmatics
- • Kidney, liver disease
- • Those allergic to NSAIDs (non-steroidal anti-inflammatory drugs)
- • Those who refuse to participate,
- • Having history of chronic analgesia use or
- • Having language barrier will be excluded.
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
mehwash nadeem, M.B.,B,S
Principal Investigator
Aga Khan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials